AJP - Regu Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 295: R1822-R1830, 2008. First published October 1, 2008; doi:10.1152/ajpregu.90625.2008
0363-6119/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/6/R1822    most recent
90625.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zuberi, Z.
Right arrow Articles by Tinker, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zuberi, Z.
Right arrow Articles by Tinker, A.

RECEPTORS AND SIGNALING PATHWAYS

The role of inhibitory heterotrimeric G proteins in the control of in vivo heart rate dynamics

Zia Zuberi,1 Lutz Birnbaumer,2 and Andrew Tinker1

1British Heart Foundation, Laboratories and Department of Medicine, University College London, London, United Kingdom; and 2National Institute of Health Sciences, Research Triangle Park, North Carolina

Submitted 23 July 2008 ; accepted in final form 30 September 2008

Multiple isoforms of inhibitory G{alpha}-subunits (G{alpha}i1,2,3, as well as G{alpha}o) are present within the heart, and their role in modulating pacemaker function remains unresolved. Do inhibitory G{alpha}-subunits selectively modulate parasympathetic heart rate responses? Published findings using a variety of experimental approaches have implicated roles for G{alpha}i2, G{alpha}i3, and G{alpha}o in parasympathetic signal transduction. We have compared in vivo different groups of mice with global genetic deletion of Gi{alpha}1/G{alpha}i3, G{alpha}i2, and G{alpha}o against littermate controls using implanted ECG telemetry. Significant resting tachycardia was observed in G{alpha}i2–/– and G{alpha}o–/– mice compared with control and G{alpha}i1–/–/G{alpha}i3–/– mice (P < 0.05). Loss of diurnal heart rate variation was seen exclusively in G{alpha}o–/– mice. Using heart rate variability (HRV) analysis, compared with littermate controls (4.02 ms2 ± 1.17; n = 6, G{alpha}i2–/–) mice have a selective attenuation of high-frequency (HF) power (0.73 ms2 ± 0.31; n = 5, P < 0.05). G{alpha}i1–/–/G{alpha}i3–/– and G{alpha}o–/– cohorts have nonsignificant changes in HF power. G{alpha}o–/– mice have a different basal HRV signature. The observed HRV phenotype in G{alpha}i2–/– mice was qualitatively similar to atropine (1 mg/kg)-treated controls [and mice treated with the GIRK channel blocker tertiapinQ (0.05 mg/kg)]. Maximal cardioinhibitory response to the M2-receptor agonist carbachol (0.5 mg/kg) compared with basal heart rate was attenuated in G{alpha}i2–/– mice (0.08 ± 0.04; n = 6) compared to control (0.27 ± 0.04; n = 7 P < 0.05). Our data suggest a selective defect of parasympathetic heart rate modulation in mice with G{alpha}i2 deletion. Mice with G{alpha}o deletion also have a defect in short-term heart rate dynamics, but this is qualitatively different to the effects of atropine, tertiapinQ, and G{alpha}i2 deletion. In contrast, G{alpha}i1 and G{alpha}i3 do not appear to be essential for parasympathetic responses in vivo.

inhibitory G proteins; heart rate; heart rate variability; parasympathetic



Address for reprint requests and other correspondence: A. Tinker, BHF Laboratories and Dept. of Medicine, Univ. College London, 5 University St., London, WC1E 6JJ (e-mail: a.tinker{at}ucl.ac.uk)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.